These conclusions are consistent with a previous report showing that NPRL2 expression is upregulated in prostate cancers and linked to poor prognosis [13] and another showing that NPRL2 depletion inhibits proliferation of prostate cancer cells [14]. This evidence concerns the gene NPRL2 and prostate carcinoma.